Cryoport, Inc. (CYRX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated May 12, 2023, details the results of Cryoport, Inc.'s 2023 Annual Meeting of Stockholders. The filing addresses corporate governance matters, specifically the election of directors, the ratification of the independent auditor, and an advisory vote on executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on voting outcomes and does not contain financial performance data.
Material Changes and Voting Results
The following proposals were submitted to stockholders and approved:
- Proposal 1: Election of Directors. All eight nominees were elected to serve until the 2024 Annual Meeting. Notable voting patterns included significant "Votes Withheld" for two nominees:
- Richard Berman: 28,709,314 votes For; 15,893,441 votes Withheld.
- Robert Hariri, M.D., Ph.D.: 26,694,207 votes For; 17,908,548 votes Withheld.
- Ramkumar Mandalam, Ph.D.: 23,771,230 votes For; 20,831,525 votes Withheld.
- Proposal 2: Ratification of Auditor. Deloitte and Touche LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2023.
- Votes For: 47,362,220
- Votes Against: 10,936
- Abstentions: 3,639
- Proposal 3: Executive Compensation Advisory Vote. The compensation of named executive officers was approved.
- Votes For: 42,966,805
- Votes Against: 1,608,485
- Abstentions: 27,465
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on operational outlook, specific risks, contingencies, or unusual items. The document is limited to the reporting of voting results.
Key Facts for Investor Verification
- Verify the reasons for the high number of "Votes Withheld" for directors Richard Berman, Robert Hariri, and Ramkumar Mandalam, as these dissenting votes may indicate shareholder concerns regarding specific board members.
- Confirm the total number of shares outstanding and the quorum status at the Annual Meeting to contextualize the voting percentages.
- Review the March 31, 2023 Proxy Statement referenced in the filing for detailed biographies of the elected directors and the specific compensation metrics approved in Proposal 3.
- Note that this filing contains no financial performance data; investors should refer to the most recent 10-Q or 10-K for financial metrics.